Pricing

Log inSign up

Capricor Therapeutics

1 follower

‌

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a clinical-stage biotechnology company focused on the development of cell and exosome-based therapeutics for the treatment and prevention of serious diseases.

Industries

Biotechnology

Headquarters

Beverly Hills, United States

Employees

11-50

Links

Org chart

Linda Marbán
Chief Executive Officer

Linda Marbán

Collapse
Aj Bergmann
Chief Financial Officer
Kristi A. H. Elliott
Chief Science Officer
Mark Awadalla
Chief Development Officer (cdo)
Yushi Feng
VP of Regulatory Affairs
Jonathan Tayco
Vice President Of Program Management, Operations And Quality
Joe Z.
Senior IP Counsel

Board & advisors

Frank Litvack
Chairman
George W. Dunbar, Jr.
Director
DM
David B. Musket
Director
Karimah Es Sabar
Director
EJ
Earl M. Collier Jr.
Director
Paul G. Auwaerter
Director
EM
Eugenio Mercuri
Scientific Advisor
OM
Oscar Henry Mayer
Scientific Advisor
PF
Pat Furlong
Scientific Advisor
ME
Michelle Eagle
Scientific Advisor
MT
Michael Taylor
Scientific Advisor
FM
Francesco Muntoni
Scientific Advisor
CM
Craig McDonald
Scientific Advisor
CV
Chet Villa
Scientific Advisor
TF
Timothy Franson
Scientific Advisor
SH
Suzanne Hendrix
Scientific Advisor
PG
Philip J. Gotwals
Director
MK
Michael Kelliher
Director

Teams

+23

Research and Development

26 members

Leadership Team

3 members

PC

Finance and Accounting

3 members

Offices

Similar companies

Calico

6 followers

Watchmaker Genomics

3 followers

Tessera Therapeutics

2 followers

Caribou Biosciences

2 followers

Vera Therapeutics

2 followers

Immunome

2 followers

Ensoma

1 follower

Entos

1 follower

Cargo

1 follower

Bionaut Labs

1 follower

Generate Biomedicines

3 followers

Explore companies